ABC | Volume 111, Nº2, August 2018

Anatomopathological Session Favarato & Aiello A 59-year-old woman with rheumatic mitral valve disease with severe dyspnea, shock and pulmonary condensation. Arq Bras Cardiol. 2018; 111(2):215-222 1. Carapetis JR,SteerAC,MulhollandEK,WeberM.Theglobalburdenofgroup A streptococcal diseases. Lancet Infect Dis 2005;5(11):685-94. 2. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470 -6. 3. Carapetis JR, Hardy M, Fakakovikaetau T, Taib R, Wilkinson L, Penny DJ, et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med. 2008;5(7):411-7. 4. Bhaya M, Panwar S, Beniwal R, Panwar RB. High prevalence of rheumatic heart disease detected by echocardiography in school children. Echocardiography. 2010;27(4):448-53. 5. Guilherme L, Kalil J, CunninghamM. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity. 2006;39(1):31-9. 6. Meira ZM, Goulart EM, Rocha FD, Bragança CA, Mota CC. Acute rheumatic fever recurrences and their influence on the progress of chronic valvular disease in children and teenagers. Revista Med Minas Gerais. 2008;18(4):236-42. 7. Mossmann TR, Cherwinski H, Bond MW, Gidlin MA, Coffman RL. Two types of murine helper T-cell clones I. Definition according to profiles of lymphokines, activities and secreted proteins. J Immunol. 1986;136(7):2348-57. 8. Bretscher PA. On the mechanism determining the Th1/Th2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment,ofcertaininfectiousdiseases.ScandJImmunol.2014;79(6):361-76. 9. Bright PD, Mayosi BM, Martin WJ. An immunological perspective on rheumatic heart disease pathogenesis: More questions than answers. Heart. 2016;102(19):1527-32. 10. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--anevidence-basedguideline.NatRevCardiol.2012;9(5):297-309. 11. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31(6):719-27. 12. Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann Intern Med. 1994;120(3):177-83. 13. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al; ACC/AHA Task ForceMembers. 2014AHA/ACCGuidelines for the management of patients with valvular heart disease: a report of the American College of Cardilogy American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(23):e521-643. Erratum in: Circulation. 2014;130(13):e120. 14. Oktay AA, Glilliland YE, Lavie CJ, Ramee SJ, Parrino PE, Bates M, et al. Echocadiographic assessment of degenerative mitral stenosis: a diagnostic challenge of an emerging cardiac disease. Curr Probl Cardiol. 2017;42(3):71-100. 15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, SmisethOA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10(2):165-93. 16. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, et al. EHRA/ HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Heart Rhythm. 2017;14(1):e3-40. 17. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al. Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J. 2004;25(3):267-76. 18. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al; International Collaboration on Endocarditis-Prospective Cohort Study (ICE- PCS) Investigators. Clinical presentation, etiology and outcome of infective endocarditisinthe21stcentury:theInternationalCollaborationonEndocarditis- Prospective Cohort Study. Arch InternMed. 2009;169(5):463-73. 19. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet. 1999;353(9162):1386-9. 20. Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis. Am J Med. 2015;128(12):1314-21. 21. Mota CC, Aiello VD, Anderson RH. Chronic rheumatic heart disease. In: Anderson RH, Baker EJ, Penny D, Redington AN, Rigby ML, Wernovsky G. (eds). Paediatric cardiology. 3 rd ed. Philadelphia: Churchill Livingstone; 2010. p. 1115-21. 22. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34-41. Erratum in: J Am Coll Cardiol. 2014;63(7):746. J Am Coll Cardiol. 2014;63(7):746. 23. Ribeiro de Campos PT, Lopes AA, Issa VS, Aiello VD. Morphologic and immunohistochemical features of pulmonary vasculopathy in end-stage left ventricular systolic failure. J Heart Lung Transplant. 2018Mar;37(3):422-5. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 222